Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Edwards Lifesciences (NY: EW )

69.29 +1.34 (+1.97%)
Official Closing Price Updated: 7:00 PM EDT, Mar 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Edwards Lifesciences

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Cramer Says 'I Have No Idea What's Happening' To A Once-Favored Stock Down 35% YTD
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Edwards Lifesciences Corporation (NYSE: EW) used to be "one of the greatest stocks of our time and, it’s now 
Via Benzinga
Expert Ratings for Edwards Lifesciences
Via Benzinga
Here's How Much You Would Have Made Owning Edwards Lifesciences Stock In The Last 10 Years
Via Benzinga
Beyond Pills: 3 Non-Pharma Healthcare Stocks for Healthy Gains
The demand for healthcare devices and tools are increasing which means their stocks will provide profits for investors. 
Via InvestorPlace
Analyst Ratings for Edwards Lifesciences
Via Benzinga
(EW) - Analyzing Edwards Lifesciences's Short Interest
Via Benzinga
$100 Invested In This Stock 15 Years Ago Would Be Worth $1,600 Today
Via Benzinga
Where Edwards Lifesciences Stands With Analysts
Via Benzinga
$100 Invested In This Stock 10 Years Ago Would Be Worth $700 Today
Via Benzinga
Barron's Weekend Stock Picks: PayPal, Nikola And Icahn Enterprises' Challenges
Benzinga reviews this weekend's top stories covered by Barron's. Here are the articles investors need to read. 
Via Benzinga
Why Willis Towers Watson Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Femasys Inc. (NASDAQ: FEMY) gained 54% to $0.55. Femasys reported a notice of allowance for new U.S. patent application covering use of FemBloc for female permanent birth control. 
Via Benzinga
Looking Into Edwards Lifesciences's Recent Short Interest
Via Benzinga
P/E Ratio Insights for Edwards Lifesciences
Via Benzinga
Where Edwards Lifesciences Stands With Analysts
Via Benzinga
US Stocks Buckle Up For Solid Open On Meta's Earnings Boost, Fed Relief — But Analyst Advises Some 'Value-Style' Rebalancing
Stocks could be heading to a higher open on Thursday, as traders digest some positive earnings reports and look ahead to another batch of economic data. 
Via Benzinga
eBay, Barclays, Edwards Lifesciences And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
U.S. stock futures traded higher this morning on Thursday. Here are some big stocks recording losses in today’s pre-market trading session. TPI Composites, Inc. (NASDAQ: TPIC) shares declined 20.3% to... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Here's How Much You Would Have Made Owning Edwards Lifesciences Stock In The Last 15 Years
Via Benzinga
Peering Into Edwards Lifesciences's Recent Short Interest
Via Benzinga
Analyst Ratings for Edwards Lifesciences
Via Benzinga
Edwards Lifesciences Sinks Despite An Earnings Beat, Outlook Increase
Edwards Lifesciences stock fell after the medtech company reported Q2 earnings. 
Via Investor's Business Daily
US Stock Futures Signal Shaky Open On Mixed Tech Earnings: Analyst Expects Fed To Adopt 'Wait-And-See' Rate Approach
The market mood could remain cautious until the Fed decision and mixed reaction to tech earnings could also weigh down on sentiment. 
Via Benzinga
Jim Cramer Says This Major Automotive Stock Is Just Too Cheap: 'That's Wrong. I Think You've Got A Winner'
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Tripadvisor, Inc. (NASDAQ: TRIP) is not good enough, and he prefers Booking Holdings Inc. (NASDAQ: BKNG). 
Via Benzinga
Here's How Much You Would Have Made Owning Edwards Lifesciences Stock In The Last 10 Years
Via Benzinga
$1000 Invested In This Stock 10 Years Ago Would Be Worth $7,400 Today
Via Benzinga
The Latest Analyst Ratings for Edwards Lifesciences
Via Benzinga
$100 Invested In This Stock 10 Years Ago Would Be Worth $800 Today
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 19, 2023
Via Benzinga
Illumina Takes AI to Genomics: Launch of PrimateAI-3D for Accurate Disease Prediction
Illumina, Inc. (NASDAQ: ILMN) launched PrimateAI-3D, an artificial intelligence (AI) algorithm that predicts disease-causing genetic mutations in patients. 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.